Editor's Choice | This Week in BMJ | Press releases
BMJ No 7123 Volume 315 Clinical review Saturday 20/27 December Christmas 1997 issue
One for the heartRichard DollSee Editorial by White and McKee, p 1638
"An ounce of whisky, please Sister," or was it half an ounce or two ounces? I cannot remember now, but I know that I prescribed some tentatively after having sought the ward sister's opinion when I was called to my first patient with lobar pneumonia as a newly qualified house physician in 1937. There was nothing else to prescribe unless oxygen was needed. In the 19th century alcohol had been prescribed for many debilitating conditions, but its medicinal use was dying out except for people who were terminally ill, and there was certainly no idea that it might be of any use in preventing disease. Some people must have seen Pearl's report in 1926 of a U shaped relation between mortality and the consumption of alcoholic beverages, but it was totally ignored by the medical profession.(1) The situation began to change soon after the second world war, with reports of an unusually low prevalence of coronary artery disease in patients found to have cirrhotic livers at necropsy.(2,3) Necropsy series were, however, subject to many biases, and these reports excited little interest. Even in the 1970s, when case-control studies of people with and without myocardial infarcts(4) and cohort studies of people with different personal characteristics(5) began to report a reduced relative risk of myocardial infarction in people who drank small or moderate amounts of alcohol in comparison with non-drinkers, scant attention was paid to them. The belief that alcohol was bad for health was so ingrained that the idea that small amounts might be good for you was hard to envisage, and it is only in the past 10 years that cardiologists and specialists in preventive medicine have begun to take it seriously.
Prophylactic value of alcoholic beveragesThe evidence for a beneficial effect is now massive.(3)(6,7) It includes not only a reduction of about a third in the risk of vascular disease but also, because vascular disease is such an important cause of death in middle and old age, a reduction in total mortality. That the reduction observed reflects a true causal relation was resisted by some specialists for many years. In many studies lifelong non-drinkers and ex-drinkers had been classed together, and Shaper et al argued that the higher mortality in non-drinkers than in light drinkers was chiefly because some who were ill, and hence at greater risk of death, had given up drinking specifically because of their illness.(8) This explanation was not tenable, however, because studies that distinguished between lifelong non-drinkers and ex-drinkers also showed J shaped or U shaped mortality curves for vascular disease and for total mortality. An example is provided by the observations by Klatsky et al on 20,000 men and women who were examined in a prepaid health plan in California and were subsequently followed up for eight years.(9) The results are summarised in table 1. Similar relations have also been found in men and women without any major disease - in the American Cancer Society's study of 490,000 Americans aged 30 years and over(10,11) and in our study of 12,000 middle aged and elderly British doctors, 5000 of whom had specifically stated that they were free from any form of vascular disease before follow up began.(12)
The suggestion by Shaper that the reduced mortality from ischaemic heart disease was due to confounding was also unsatisfactory,(13) as most factors that are known to increase the risk of the disease are either independent of alcohol consumption or positively associated with it and so make the observed effect seem less than it really is - for example, smoking, a high fat diet with little fruit and green vegetables, raised blood pressure, and a high body mass index.(14) Socioeconomic factors, which could have confounded the results of some studies, cannot have done so to any material extent in the comparatively homogeneous sample of British doctors and, although physical activity might have done so to some extent, it could account for only a small part of the observed relation.(12) Some direct beneficial effect is, moreover, physiologically plausible, as is shown later, and the observed relation with vascular disease is most economically explained as one of cause and effect - a conclusion that has been accepted by the independent group of scientists that was commissioned by the European Office of the World Health Organisation to prepare a report on alcohol and public policy.(15)
These include several other vascular diseases, cholelithiasis,(16,17) and non-insulin dependent diabetes mellitus,(18) which Kiechl et al suggest may be reduced in incidence because alcohol improves insulin sensitivity.(19) Many other questions also remain to be answered, some of which are socially important. One is the level of consumption at which the minimum mortality is obtained; another is the variation in the balance of overall risk with sex and age; and a third is the difference, if any, between the effects of the different types of alcoholic beverage - beer, spirits, and wine. Optimal consumptionEstimates of the effect of different quantities of alcohol are particularly difficult to make, principally because habits vary and people find it difficult to describe accurately their pattern of drinking and how much they drink over any prolonged period. Heavy drinkers are likely to underestimate the amount, but so are moderate and light drinkers in societies in which the consumption of alcohol may be disapproved of, as in parts of the United States. In some surveys consumption has underestimated sales figures by as much as 30-80%.(20,21) Furthermore, the official definition of a unit of consumption varies from one country to another: from as little as 6.3 g of ethanol in spirits in Austria to as much as 19.75 g in Japan. British units are uniformly defined as 8 g, which corresponds to the amount of ethanol in half a pint of beer (3.5% of alcohol by volume), but this is certainly less than most people would expect to get in a glass of wine and much less than in the tot of spirits that they would pour for themselves at home. The US unit, in contrast, is variously defined as 12 g or 14 g. It is not surprising, therefore, that the minimum mortality has been found to occur at different levels of consumption in different studies. When Poikolainen reviewed 29 studies he found that the consumption associated with minimum mortality varied from less than one drink a day to five, with one being the most frequently reported.(7) Over half of the studies, however, were American and consequently the amounts drunk were probably underestimated. As, moreover, the American units are some 50% larger than the British, it may be that in terms of British drinks the finding in the study of elderly British doctors that the minimum mortality was associated with two or three drinks a day provides a more accurate picture. Variation with age and sexSome of the variation reported could, however, result from differences in the age distribution of the populations studied, for the ratio of the mortality from conditions that are prevented by alcohol and that from conditions that are made more common by it varies greatly with age. This is illustrated by the death rates from ischaemic heart disease and external injury and poisoning recorded in the developed countries with market economies in 1990. The ratios of these rates are shown for four age groups in table 2.(22) Alcohol, it would seem, is unlikely to produce any reduction in total mortality under about 45 years of age. The contrast is illustrated by the results of two studies, one of a cohort of young conscripts in the Swedish army, which showed a steadily increasing mortality with amount drunk at all levels of consumption(23) and one of Massachusetts men aged 65 years and over,(24) which showed a progressive reduction in mortality up to about three American or four British units a day.
Variation with type of drinkThere remains the question of the type of drink that produces benefit. The idea that it might differ with different types arose from an attempt by Cochrane and his colleagues of the Medical Research Council's epidemiology unit to dissect out the social and environmental factors that determined mortality in 18 developed countries.(27,28) Their findings for ischaemic heart disease at ages 55 to 64 are shown in table 3. The strong negative correlation with the consumption of alcohol was independent of, and almost as strong as, the positive correlation with the predictive index for the effect of different combinations of dietary fat given by Keys's equation.(29) The correlation with alcohol was not surprising, but it was surprising that it should have been entirely explained by the correlation with the consumption of wine (r=-0.70 for men and -0.61 for women).
Cochrane and his colleagues were well aware of the potential
pitfalls of ecological studies and were restrained in their
conclusions. If, however, wine had a specific protective effect it
might, they thought, be due to constituents other than alcohol, and
they suggested that the next step would be "to examine the effect
of alcohol and, in particular, wine on blood lipids, platelet
aggregation, and such other blood constituents as may plausibly be
involved in the pathogenesis of atheroma."(28)
Then, if the results were sufficiently pr In the event, many subsequent studies produced similar results. A few,
however, showed the greatest effect with beer or spirits, while others
showed similar effects with all three types.(30,31)
Experiments have shown that ethanol increases the blood concentration
of both high density lipoprotein cholesterol and apolipoproteins A1 and
A2 and slightly reduces the level of low density lipoprotein
cholesterol,(7)(32) reduces the aggregability of blood
platelets,(33) decreases the concentration of
fibrinogen,(34) and increases the activity of the
fibrinolytic system,(35) all of which would tend to reduce
the risk of myocardial infarction and vascular disease in general. In
contrast with these benefits, large amounts of ethanol increase blood
pressure, but there seems to be a threshold for this harmful effect at
about three British units a day.(14) There is no
experimental evidence to show that any particular alcoholic beverage
has a more beneficial effect on blood constituents or blood pressure
than the equivalent amount of ethanol. And the idea that antioxidants
or flavenoids or any other specific constituent of wine provides an
additional benefit is entirely speculative.
That wine should have been associated with greater benefit than beer or
spirits in ecological studies and in many case control and cohort
studies can be explained by differences in the pattern of drinking. The
effects of ethanol on blood constituents that affect the risk of
thrombosis last less than 24 hours, and Jackson et al have found that
this is reflected clinically in an association between the risk of
myocardial infarction and the consumption of alcohol within 24 hours,
irrespective of the number of drinks a week.(37) A similar
finding was obtained in New South Wales by McElduff and Dobson, who
also observed that greater benefit was obtained when comparatively
small amounts were taken regularly, which is the way wine is drunk in
many countries, than when the same total amount was taken one or two
days a week, in the way that beer and spirits often tend to be
drunk.(38)
There is no specific benefit associated with one type of beverage, but
the benefit derives from the content of ethanol and the extra benefit
associated with wine in some studies can be accounted for by
differences in the pattern of drinking.
The formulation of public policy is complicated by the
conclusion that a certain amount of alcohol can have a beneficial
effect on personal health, decreasing mortality from some major
conditions to such an extent that in middle and old age it more than
compensates for an increased mortality from others. Previously, policy
could, and generally did, aim to discourage drinking altogether.
Policies aimed solely at reducing heavy drinking had little success,
and the most effective means of reducing the social and medical effects
of alcohol misuse was to reduce the average amount consumed by the
population as a whole, something that could be readily achieved by
increasing taxation.
Precisely what public health policy should now be will not be the same
everywhere, for the importance of vascular thrombosis, which may be
alleviated by alcohol, and of trauma, which may be increased by it,
varies enormously not only with age and sex but also from one country
to another. This is shown in table 4, which gives for different parts
of the world and for each sex the variation in the ratio of the number
of deaths attributed to ischaemic heart disease and the number
attributed to violence, omitting only deaths attributed to the
operation of war. The ratio varies eightfold from the market economies
of the developed world and the Middle East to China and the countries
of Africa south of the Sahara, from 4.1:1 to 0.5:1 in men and from
11.5:1 to 1.7:1 in women. The balance of benefit and harm from the
consumption of alcohol must therefore be different in different
countries, and policies that might be good in one country could be
disastrous in another. The harm that may be done by the relaxation of
controls in unstable social circumstances is illustrated by the
increase in total mortality in Russia between 1987 and 1994, which is
most plausibly explained by the increase in the consumption of alcohol,
aggravated, perhaps, by the more toxic effects associated with alcohol
that is produced illicitly(39).
In Britain, where the effects on overall mortality for a person who
drinks alcohol is in later life strongly in favour of benefit, other
factors also have to be taken into account, such as the social effects
of intoxication and chronic alcoholism and the effect of drinking even
quite small amounts on the handling of vehicles and machinery. In our
study of British doctors we examined the effect of the consumption of
alcohol only on their own mortality and not on that of their patients.
I have not attempted to quantify such other effects and it would not,
therefore, be appropriate to suggest how national policy in this
country should now be formulated in its
entirety. People should be treated as adults and should be told the facts. These
still need to be refined in detail, but in broad outline they are quite
clear: in middle and old age some small amount of alcohol within the
range of one to four drinks each day reduces the risk of premature
death, irrespective of the medium in which it is taken.
I thank Green College for having stimulated me to
prepare a lecture in memory of Archie Cochrane, on which this article
is largely based; a version of the lecture was also included in one
chapter of Non-Random Reflections on Health Services
Research,(31) and I also thank Professor Richard
Peto for comments on the first draft.
Clinical Trial Service Unit and Epidemiological Studies
Unit, References
1 Pearl R. Alcohol and
longevity. New York: Alfred A Knopf, 1926.
2 Hall E M, Olsen A Y, Davis F E. Clinical and pathologic review of
782 cases from 16,600 necropsies. Am J Pathol
1953;29:993-1027.
3 Moore R D, Pearson T A. Moderate alcohol consumption and
coronary heart disease. Medicine 1986;65:242-67.
4 Klatsky A L, Friedman D G, Siegelaub A D. Alcohol consumption
before myocardial infarction. Results from the Kaiser-Permanente
epidemiologic study of myocardial infarction. Ann Intern
Med 1974;81:294-301.
5 Stason W B, Neff R K, Miettinen O S, Jick H. Alcohol consumption
and non-fatal myocardial infarction. Am J Epidemiol
1976;104:603-8.
6 Marmot M, Brunner E. Alcohol and cardiovascular disease: the
status of the U-shaped curve. BMJ 1991;303:565-8.
7 Poikolainen K. Alcohol and mortality: a review. J Clin
Epidemiol 1995;488:445-65.
8 Shaper A G, Wannamethee G, Walker M. Alcohol and mortality:
explaining the U-shaped curve. Lancet 1988;ii:1268-73.
9 Klatsky A L, Armstrong M A, Friedman G D. Risk of cardiovascular
mortality in alcohol drinkers, ex-drinkers and non-drinkers. Am
J Cardiol 1990;66:1237-43.
10 Boffeta P, Garfinkel L. Alcohol drinking and mortality among
men enrolled in an American Cancer Society prospective study.
Epidemiology 1990;1:342-8.
11 Thun M J, Peto R, Lopez A D, Monaco J H, Henley S J, Heath C W, Doll
R. Alcohol consumption and mortality in middle-aged and elderly US
adults. N Engl J Med 1997;337:1705-14.
12 Doll R, Peto R, Hall E, Wheatley K, Gray R. Mortality in
relation to consumption of alcohol: 13 years' observations on male
British doctors. BMJ 1994;309:911-8.
13 Shaper A G. Alcohol and coronary heart disease. Eur Heart
J 1995;16:1760-4.
14 Doll R, Peto R, Hall E, Wheatley K, Gray R. Alcohol and
coronary heart disease reduction among British doctors: confounding or
causality? Eur Heart J 1997;18:23-5.
15 Edwards G, Anderson P, Babor T F, Casswell S, Ferrence R,
Giesbrecht N, et al. Alcohol policy and the public good.
Oxford: Oxford University Press, 1994.
16 Thornton J, Heaton K, Syme S. Moderate alcohol intake reduces
bile cholesterol saturation and raises HDL cholesterol.
Lancet 1986;ii:819-21.
17 English D R, Holman C D J, Milne E, Winter M G, Hulse G K, Lewin GF,
et al. The quantification of drug caused morbidity and mortality
in Australia 1995. Canberra:Australian Government Publishing
Service, 1995.
18 Rimm E B, Stampfer M J, Colditz G A, Willett W C. Prospective study
of cigarette smoking, alcohol use, and the risk of diabetes in men.
BMJ 1995;310:555-9.
19 Kiechl S, Willett J, Poewe W, Eggar G, Oberhollenzer F, Muggeo
M, et al. Insulin sensitivity and regular alcohol consumption: large
prospective, cross sectional population study (Bruneck study).
BMJ 1996;313:1040-4.
20 Polich J M. Epidemiology of alcohol abuse in military and
civilian populations. Am J Public Health 1981;1:1125-32.
21 Simpura J. Finnish drinking habits: results from
interview surveys held in 1968, 1976 and 1985. Helsinki:
Finnish Foundation for Alcohol Studies, 1987.
22 Murray C J L, Lopez A D. In: The global burden of
disease. Geneva: World Health Organisation, 1996.
23 Andréasson S, Romelsjo A, Allebeck P. Alcohol and mortality
among young men: longitudinal study of Swedish conscripts.
BMJ 1988;296:1021-5.
24 Colditz G A, Branch L G, Lipnick R J, Willett W C, Rosner B, Posner
B, et al. Moderate alcohol and decreased cardiovascular
mortality in an elderly cohort. Am Heart J
1985;198:886-9.
25 Montaigne M. Essais de Messire Michel Seigneur de
Montaigne Chevalier de l'Ordre du Roy et Gentilhomme Ordinaire de sa
chambre. Translated by E J Trechmann as The Essays
of Montaigne. Oxford: Oxford University Press,
1995.
26 Longnecker M P. Alcoholic beverage consumption in relation to
risk of breast cancer: meta-analysis and review. Cancer Causes
Control 1994;5:73-82.
27 Cochrane A L, St Leger A S, Moore F. Health service "input"
and mortality "output" in developed countries. J Epidemiol
Community Health 1978;32:200-5.
28 St Leger A S, Cochrane A L, Moore F. Factors associated with
cardiac mortality in developed countries with particular reference to
the consumption of wine. Lancet 1979;i:1017-20.
29 Keys A, Anderson J T, Grande F. Prediction of serum-cholesterol
responses of man to changes in fats in the diet. Lancet
1957;ii:959-66.
30 Rimm E B, Klatsky A, Grobbee D, Stampfer M J. Review of moderate
alcohol consumption and reduced risk of coronary heart disease: is the
effect due to beer, wine, or spirit? BMJ 1996;312:731-6.
31 Doll R. Cochrane and the benefits of wine. In: Maynard A,
Chalmers I, eds. Non-random reflections on health services
research. London: BMJ Publishing Group, 1997.
32 Haskell W L, Camargo C, Williams P T, Vranizan K M, Krauss R M,
Lindgren FT, et al. The effect of cessation and resumption of moderate
alcohol intake on serum high density lipoprotein sub-fractions: a
controlled study. N Engl J Med 1984;310:805-10.
33 Renaud S C, Beswick A D, Fehily A M, Sharp P S, Elwood PC. Alcohol
and platelet aggregation: the Caerphilly prospective heart disease
study. Am J Clin Nutr 1992;55:1012-7.
34 Meade J W, Imeson J, Stirling Y. Effects of changes in smoking
and other characteristics on clotting factors and the risk of ischaemic
heart disease. Lancet 1987;ii:986-8.
35 Hendriks H F, Veenstra J, Wierik E J M V, Schaafsma G, Kluft C.
Effect of moderate dose of alcohol with evening meal on fibrinolytic
factors. BMJ 1994;308:1003-6.
36 Criqui M H. Alcohol and hypertension: new insights from
population studies. Eur Heart J 1987;8 (suppl B):73-85.
37 Jackson R, Scragg R, Beaglehole R. Does recent
alcohol consumption reduce the risk of acute myocardial infarction and
coronary death in regular drinkers? Am J Epidemiol
1992;136:819-24.
38 McElduff P, Dobson A J. How much alcohol and how often?
Population based case-control study of alcohol consumption and risk of
a major coronary event. BMJ1997;314:1159-64.
39 Leon D A, Chenet L, Shkolnikov V M, Zakharov S, Shapiro J,
Rakhmanova G, et al. Huge variation in Russian mortality rates 1984-94:
an artefact, alcohol, or what? Lancet
1997;350:383-8.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||